ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1437

Majority of Lupusqol Domains Are Negatively Correlated with Systemic Lupus Activity Questionnaire (SLAQ) Score

Wendy Marder1, Martha Ganser1, Margaret Hyzy2 and Emily C. Somers3, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Internal Medicine, Universitiy of Michigan, Ann Arbor, MI, 3IntMed, Environmental Health, and OB/GYN, University of Michigan, Ann Arbor, MI

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Health Assessment Questionnaire, quality of life and questionnaires

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic lupus erythematosus (SLE) disease activity measures such as the SLEDAI and BILAG require real time physician and laboratory assessment of patients, making them difficult to use in large, epidemiologic studies. The Systemic Lupus Activity Questionnaire (SLAQ) is a self-administered tool developed specifically for screening purposes and epidemiologic studies, and takes a lupus patient < 5 minutes to complete. While the SLAQ is not intended for clinical management or in lieu of physician assessment for disease management purposes, it has been validated in a large community based cohort in response to other health indices such as SF12 and SF 36.  We assessed correlations between these two self-administered SLE disease measures in a cohort of well characterized SLE patients at a large tertiary care outpatient setting.

Methods: SLE patients from the University of Michigan rheumatology clinics who met 4 or more ACR criteria and age 18 years or older were enrolled. Patients completed SLAQ and LupusQoL questionnaires, as well as sociodemographic data. The total SLAQ score is calculated on a scale of 0-47, with groups of symptoms aggregated and assigned different weights.  LupusQOL consists of 34 items, grouped as 8 domains.  Pearson’s correlation was utilized to assess the strength of associations between overall disease activity and individual QOL domains.

Results: 100 adult SLE patients responded, including 89 females and 11 males.  Mean age was 40 years (sd 13 range 18-71).  Patients were 66% White, 21% Black, 11% Other, 2% not reported.   Mean SLAQ score was 13.3 (SD 9.0, range 0 to 39).  SLAQ score (0-47 scale) was negatively associated with all QOL domains except body image, including physical health, pain, planning, intimate relationships, burden to others, emotional health, and fatigue.   Pearson correlation coefficients ranged between -0.39 and -0.70.

Conclusion: Using lupus-specific self-report measues, increased disease activity (by SLAQ) is associated with reduced QOL (by LupusQOL) in 7 of 8 domains. While QOL measures have been examined more thoroughly in the context of physician-measured disease activity measures, data are needed in relation to patient-reported lupus activity in order to provide the basis for more extensive evaluation of these concepts in the epidemiologic setting.  The total SLAQ score is negatively associated with nearly all domains of the LupusQoL questionnaire, supporting its utility in self-report SLE disease assessment.


Disclosure:

W. Marder,
None;

M. Ganser,
None;

M. Hyzy,
None;

E. C. Somers,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/majority-of-lupusqol-domains-are-negatively-correlated-with-systemic-lupus-activity-questionnaire-slaq-score/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology